miR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington’s disease
Findings demonstrate that critical role of Rad23b in miR-196a-reduced pathological aggregates is demonstrated, and highly suggest downregulating Rad23b or disrupting its interaction with mHTT may offer novel strategies to mitigate mHTT aggregates to delay disease progression.